Danaher Corp. (DHR) reported third quarter EPS of $1.00 Thursday morning, up from $0.87 in the prior year period. Analysts expected EPS of $0.95. The company expects to report fourth quarter adjusted EPS of $1.12 to $1.16 and full year adjusted EPS of $3.96 to $4.00. The consensus estimates are for EPS of $1.16 and $3.96.
Adobe Systems Inc. (ADBE) reaffirmed its fourth quarter non-GAAP EPS forecast of $1.15 after the close Wednesday. The company also forecast full year 2018 non-GAAP EPS of $5.50. Street expectations are for EPS of $5.21.
Spectrum Pharmaceuticals Inc. (SPPI) announced Tuesday that the interim data from its Phase 2 clinical study of poziotinib in EGFR Exon 20 Mutant Non-Small-Cell Lung Cancer was presented in Yokohama, Japan.
AnaptysBio Inc. (ANAB) reported positive results from its Phase 2a trial of ANB020 Tuesday morning. An Eczema Area Severity Index score improvement of 50 percent relative to enrollment baseline was observed in 75 percent of patients after a single dose.